In vivo inactivation of aminoglycosides by antipseudomonal penicillins in patients with renal failure can be a significant problem when these drugs are used together in certain gram-negative infections. Our article illustrates the possible magnitude of this interaction and the resultant effect on aminoglycoside pharmacokinetic parameters. Penicillin concentrations remain relatively unaffected by this interaction. This article stresses the need for close monitoring of aminoglycoside concentrations when combined with antipseudomonal penicillins in this patient population.
Get full access to this article
View all access options for this article.
References
1.
RiffUJacksonCG. Laboratory and clinical conditions for gentamicin inactivation by carbenicillin. Arch Intern Med1972; 130: 887–91.
2.
PickeringLKGearhartP. Effect of time and concentration upon interacting between gentamicin, tobramycin, netilmicin, or amikacin and carbenicillin or ticarcillin. Antimicrob Agents Chemother1979; 15: 592–6.
3.
HaleDCJenkinsRMatsenJM. In-vitro inactivation of aminogycoside antibiotics by piperacillin and carbenicillin. Am J Clin Pathol1980; 74: 316–9.
4.
HendersonJLPolkREKlineBJ. In vitro inactivation of gentamicin, tobramycin, and netilmicin by carbenicillin, azlocillin, or mezlocillin. Am J Hosp Pharm1981; 38: 1167–70.
5.
ErvinFRBullockWENuttallCE. Inactivation of gentamicin by penicillins in patients with renal failure. Antimicrob Agents Chemother1976; 9: 1004–11.
6.
DaviesMMorganJRAnandC. Interactions of carbenicillin and ticarcillin with gentamicin. Antimicrob Agents Chemother1975; 7: 431–4.
7.
BlairDCDugganDOSchroederET. Inactivation of amikacin and gentamicin by carbenicillin in patients with end-stage renal failure. Antimicrob Agents Chemother1982; 22: 376–9.
8.
ThompsonMIBRussoMESaxonBJAtkinthorEMatsenJM. Gentamicin inactivation by piperacillin or carbenicillin in patients with end-stage renal disease. Antimicrob Agents Chemother1982; 21: 268–73.
9.
DettliLC. Drug dosage in patients with renal disease. Clin Pharmacol Ther1974; 16: 274–80.
10.
De SchepperPJTjandramagaTBMullieA. Comparative pharmacokinetics of piperacillin in normals and in patients with renal failure. J Antimicrob Chemother1982; 9 (suppl B):49–57.
